Mitotax 250mg Injection Vial

babies: not applicable lactating mothers: it is contraindicated. studies have shown evidence of medicine in breast milk.
it may cause toxicity to the baby. pregnancy: it is unsafe to use in pregnancy.
seek doctor advice. driving: mitotax injection may decrease alertness and may cause dizziness.
do not drive if these symptoms occur. alcohol: avoid consumption of alcohol while taking this medicine as it causes severe liver damage.
kidney: mitotax injection is safe to use in patients with kidney disease. please consult your doctor if you have severe liver problems.
liver: mitotax injection should be used with caution in patients with liver disease. dose adjustment is required, and it is not recommended in patients with severe liver disease.
.

nausea vomiting hair loss severe stomach pain diarrhea anemia irritation at the injection site low blood pressure tingling or burning in your hands and feet fever joint and muscle pain.

mitotax is an anticancer medicine it works by interfering with the microtubule structures, which help the cancer cells to divide and multiply. it slows the growth of cancer cells and kills them..

please contact your doctor immediately.

• do not take mitotax injection if you are a lactating mother. it may cause toxicity to the baby • do not self administer this injection.
your doctor or nurse will give you this medicine. • go for regular liver function tests and blood tests while taking this medicine • if you notice unexplained bleeding, sore throat, mouth ulcers, and fever inform your doctor immediately • do not use the injection if the solution contains visible particulate matter • talk to your doctor if you have sudden weight gain or swelling in legs and arms while taking this medicine .

monitor closely • mitotax + clozapine: concurrent use may lead to a decrease in the white blood cell count • mitotax + diltiazem: concurrent use may lead to a decrease in the white blood cell count • mitotax + cisplatin: concurrent use may lead to an increase in the risk of renal failure • mitotax + atorvastatin: concurrent use may lead to an increase in the nerve damage serious • mitotax + idarubicin: concurrent use may lead to an increase in the toxicity of idarubicin minor • mitotax + prednisone: concurrent use may lead to a decrease in the effect of mitotax .